chrX-136666211-C-CA
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP6_Moderate
The NM_004840.3(ARHGEF6):c.*1817dupT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000177 in 112,857 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 24)
Consequence
ARHGEF6
NM_004840.3 3_prime_UTR
NM_004840.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.259
Genes affected
ARHGEF6 (HGNC:685): (Rac/Cdc42 guanine nucleotide exchange factor 6) Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein belongs to a family of cytoplasmic proteins that activate the Ras-like family of Rho proteins by exchanging bound GDP for GTP. It may form a complex with G proteins and stimulate Rho-dependent signals. This protein is activated by PI3-kinase. Mutations in this gene can cause X-chromosomal non-specific cognitive disability. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant X-136666211-C-CA is Benign according to our data. Variant chrX-136666211-C-CA is described in ClinVar as [Likely_benign]. Clinvar id is 367925.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF6 | NM_004840.3 | c.*1817dupT | 3_prime_UTR_variant | 22/22 | ENST00000250617.7 | NP_004831.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF6 | ENST00000250617 | c.*1817dupT | 3_prime_UTR_variant | 22/22 | 1 | NM_004840.3 | ENSP00000250617.6 | |||
ARHGEF6 | ENST00000370622.5 | c.*1817dupT | 3_prime_UTR_variant | 21/21 | 1 | ENSP00000359656.1 | ||||
ARHGEF6 | ENST00000370620.5 | c.*1817dupT | 3_prime_UTR_variant | 21/21 | 2 | ENSP00000359654.1 |
Frequencies
GnomAD3 genomes AF: 0.0000177 AC: 2AN: 112804Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 34942
GnomAD3 genomes
AF:
AC:
2
AN:
112804
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
34942
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
GnomAD4 genome AF: 0.0000177 AC: 2AN: 112857Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35005
GnomAD4 genome
AF:
AC:
2
AN:
112857
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
35005
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Non-syndromic X-linked intellectual disability Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at